| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |